BioStem Technologies, Inc. (OTCMKTS:BSEM – Get Free Report) was the recipient of a large growth in short interest during the month of July. As of July 31st, there was short interest totalling 63,500 shares, a growth of 25.7% from the July 15th total of 50,500 shares. Based on an average daily trading volume, of 35,700 shares, the short-interest ratio is presently 1.8 days.
BioStem Technologies Stock Performance
BSEM traded down 0.63 during mid-day trading on Friday, reaching 11.99. The stock had a trading volume of 51,200 shares, compared to its average volume of 26,461. The stock has a market capitalization of $195.29 million, a P/E ratio of 32.05 and a beta of 0.03. BioStem Technologies has a 52 week low of 1.21 and a 52 week high of 15.50. The firm’s fifty day simple moving average is 9.16 and its two-hundred day simple moving average is 9.29.
BioStem Technologies (OTCMKTS:BSEM – Get Free Report) last posted its quarterly earnings results on Monday, August 12th. The company reported 0.30 earnings per share for the quarter, topping the consensus estimate of 0.12 by 0.18. The firm had revenue of 74.49 million for the quarter, compared to the consensus estimate of 43.99 million. As a group, analysts expect that BioStem Technologies will post 0.49 EPS for the current fiscal year.
About BioStem Technologies
BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.
Recommended Stories
- Five stocks we like better than BioStem Technologies
- Market Cap Calculator: How to Calculate Market Cap
- JD.com Earnings Surprise: China’s Outlook Better Than Expected
- Options Trading – Understanding Strike Price
- Warren Buffett’s Recent Stock Moves: Top Buys and Sells to Watch
- Stock Market Upgrades: What Are They?
- Sea Limited’s E-Commerce and Fintech Strength Fuel Stock Surge
Receive News & Ratings for BioStem Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioStem Technologies and related companies with MarketBeat.com's FREE daily email newsletter.